会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 74. 发明授权
    • Medicament containing Epimedium extract for treatment of prostatic hyperplasia and prostatitis
    • 含有淫羊藿提取物的药物用于治疗前列腺增生和前列腺炎
    • US07250182B2
    • 2007-07-31
    • US11476458
    • 2006-06-28
    • Hui Dong
    • Hui Dong
    • A61K36/25A61K36/00
    • A61K36/296A61K36/00A61K36/258A61K36/481A61K36/756A61K2300/00
    • This present invention relates to a method for extracting Epimedium herb to prepare flavones and polysaccharides combinations in which their ratios vary from 2:8 to 8:2 by weight and applying these extracted compositions in treatment of prostatic hyperplasia. Total flavones of the extracts are in the range of 20-90% and the molecular weights of extracted polysaccharides vary from 1,000 to 700,000 Daltons. This invention also includes a method for preparing compounded formulations which contain extracts of Radix Ginseng, pollens, Radix Astragali, Cortex Phellodendri, Epimedium flavones and polysaccharides and administering these compositions directed at treatment of prostatic hyperplasia and prostatitis. Clinical study has showed that these extracts and formulations are effective in treatment of prostate illness with no adverse reactions.
    • 本发明涉及一种用于提取淫羊藿草本以制备黄酮和多糖组合的方法,其中它们的比例为2:8至8:2重量比,并将这些提取的组合物应用于前列腺增生的治疗。 提取物的总黄酮在20-90%的范围内,提取的多糖的分子量在1,000至700,000道尔顿之间变化。 本发明还包括制备含有人参,花粉,黄芪,皮质黄柏,淫羊藿黄酮和多糖的提取物的复合制剂的方法,并且这些组合物用于治疗前列腺增生和前列腺炎。 临床研究表明,这些提取物和制剂对前列腺疾病的治疗有效,无不良反应。